Murcko scaffold
Ring system with 3 rings and 30 atoms
76 chemicals on CompoundList share this ring system.
- Rings
- 3
- Scaffold atoms
- 30
- Chemicals
- 76
- With full pages
- 8
Scaffold SMILES
N=C1CCCCOC(=O)CC(OC2CCCCO2)CC(OC2CCCCO2)CCC1
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 48 of 76 chemicals
11-((2-Dimethylaminoethyl)oxymethyl)erythromycin A 9-methoxime
CAS 107749-17-7C43H81N3O14
Roxithromycin, (Z)-
CAS 134931-00-3C41H76N2O15
(9Z)-Erythromycin A oxime
CAS 134931-01-4C37H68N2O13
Lexithromycin
CAS 53066-26-5C38H70N2O13
RefChem:401092
CAS 111321-02-9C37H68N2O13
Roxithromycin
CAS 80214-83-1C41H76N2O15
Clarithromycin 9-oxime
CAS 103450-87-9C38H70N2O13
N-Demethyl roxithromycin
CAS 118267-18-8C40H74N2O15
(E)-O-Demethylroxithromycin
CAS 261172-58-1C40H74N2O15
Clarithromycin oxime
CAS 127253-05-8C38H70N2O13
N-Desmethyl-6-O-methylerythromycin (9E)-Oxime
CAS 127182-43-8C37H68N2O13
Erythromycin, 6-O-methyl-, 9-oxime, (9Z)-
C38H70N2O13
Roxithromycin impurity 21
CAS 51830-04-7C37H68N2O12
2',4''-O-Bis(trimethylsilyl)erythromycin A 9-O-(1-Ethoxy-1-methylethyl)oxime
C47H92N2O14Si2
6-O-Methyl-2',4''-bis-O-(trimethylsilyl)erythromycin 9-[O-(1-ethoxy-1-methylethyl)oxime]
C48H94N2O14Si2
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[4-(Dimethylamino)-6-methyl-3-trimethylsilyloxyoxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(4-methoxy-4,6-dimethyl-5-trimethylsilyloxyoxan-2-yl)oxy-10-(2-methoxypropan-2-yloxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
CAS 119665-76-8C47H92N2O14Si2
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(3S,4R,6S)-4-(Dimethylamino)-6-methyl-3-trimethylsilyloxyoxan-2-yl]oxy-10-(2-ethoxypropan-2-yloxyimino)-14-ethyl-12,13-dihydroxy-7-methoxy-4-[(4R,5S,6S)-4-methoxy-4,6-dimethyl-5-trimethylsilyloxyoxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
C49H96N2O14Si2
Erythromycin, 6-O-methyl-2',4''-bis-O-(trimethylsilyl)-, 9-[O-(1-ethoxy-1-methylethyl)oxime]
CAS 119665-62-2C49H96N2O14Si2
Erythromycin A oxime
CAS 13127-18-9C37H68N2O13
Clarithromycin impurity G
CAS 127182-44-9C39H72N2O13
2',4''-Bis-O-(trimethylsilyl)-9-[O-(1-ethoxy-1-methylethyl)oxime] erythromycin
CAS 1253181-38-2C48H94N2O14Si2
2'-O-[(2-Methoxyethoxy)methyl] Roxithromycin
CAS 425365-66-8C45H84N2O17
3/'-De(diMethylaMino)-3/'-[[(2-Methoxyethoxy)Methyl]diMethylaMMonio]erythroMycin 9-OxiMe Chloride
CAS 151750-47-9C41H77ClN2O15
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-10-(2-methoxyethoxymethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
C42H78N2O16
- 1 suppliersRoxithromycin impurity FC40H74N2O15
- (3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(Dimethylamino)-6-methyl-3-trimethylsilyloxyoxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-7-methoxy-4-[(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-trimethylsilyloxyoxan-2-yl]oxy-10-(2-methoxypropan-2-yloxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-oneC48H94N2O14Si2
- Intermediate of clarithromycinC49H96N2O14Si2
- 1 suppliersClarithromycin impurity L127253-06-9C38H70N2O13
- 1 suppliersRoxithromycin EP impurity G425365-64-6C42H78N2O16
- 2 suppliersClarithromycin impurity O127252-80-6C39H72N2O13
- Clarithromycin (9Z)-O-methyloximeC39H72N2O13
- 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)-9-[O-(1-ethoxy-1-methylethyl)oxime]-ErythromycinC49H96N2O14Si2
- Clarithromycin 9-oximeC38H70N2O13
- N-Demethyl roxithromycinC40H74N2O15
- Clarithromycin EP impurity LC38H70N2O13
- 1 suppliersRoxithromycin EP impurity H425365-65-7C41H76N2O14
- 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)-9-[O-(1-ethoxy-1-methylethyl)oxime]-ErythromycinC49H96N2O14Si2
- 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)erythromycin-9-[O-(1-ethoxy-1-methylethyl)oxime]C49H96N2O14Si2
- 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)erythromycin9-[O-(1-ethoxy-1-methylethyl)oxime]C48H94N2O14Si2
- (3R,4R,5R,6S,7R,9S,10E,11S,12R,14S)-6-[4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-10-(2-methoxyethoxymethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-oneC42H78N2O16
- Erythromycin, 9-oxime, (9Z)-C37H68N2O13
- Erythromycin, 9-[O-[2-(dimethylamino)ethyl]oxime]80214-86-4C41H77N3O13
- Erythromycin, 9-oxime, monohydrochloride26116-57-4C37H69ClN2O13
- Intermediate of clarithromycinC49H96N2O14Si2
- Erythromycin,6-O-methyl-2',4''-bis-O-(trimethylsilyl)-, 9-[O-(1-methoxy-1-methylethyl)oxime]C48H94N2O14Si2
- Clarithromycin impurity CC38H70N2O13
- 2',4''-O-Bis(trimethylsilyl)-6-O-methylerythromycin A 9-[O-(1-methoxy-1-methylethyl) Oxime119699-81-9C48H94N2O14Si2
- Erythromycin, 2',4''-bis-O-(trimethylsilyl)-, 9-[O-(1-ethoxy-1-methylethyl)oxime]C47H92N2O14Si2